VANCOUVER, Sept. 14 /PRNewswire/ - According to a new report by iData Research (www.idataresearch.net), the leading global authority in medical device and pharmaceutical market research, the market for cosmetic surgery, facial aesthetics and medical lasers is expected to almost double in size, exceeding $3 billion by 2017. The market for aesthetic Botulinum toxin-A drugs such as Botox(R) will grow to an estimated $543 million by 2017, while the aesthetic laser and light therapy markets for skin resurfacing, hair removal and laser lipolysis are the fastest growing segments.
"Allergan has had a monopoly on Botulinum toxin A drugs since 2002, but now faces competition from Dysport(R) by Medicis as well as other new competitors expected to enter the market," says Dr. Kamran Zamanian, CEO of iData. "Allergan and Medicis have been fierce rivals, as their Juvederm(R) and Restylane(R) facial dermal fillers compete in the lucrative dermal filler market."
The report states that the U.S. market for aesthetic facial injectable products is valued at almost $860 million in 2010. Competition will intensify with the expected entry of PurTox(R) by Mentor Corporation, a subsidiary of Johnson & Johnson. Use of Botulinum toxin is also expected to increase due to a growing number of therapeutic possibilities, such as upper limb spasms, neck malpositioning due to spastic musculature and certain types of eye muscle disorders.
"A growing number of doctors are looking at the therapeutic potential of Botulinum-A. There are more cosmetic procedures performed using Botulinum-A than therapeutic, however therapeutic procedures use higher doses of the drug, therefore these two markets are similar in value," says Dr. Zamanian.
iData's Global 3-report series, the "Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011" includes the latest data, market analyses and competitor profiles for: Botulinum toxin, dermal filler, augmentation implants, liposuction aspirators, laser/light devices and microderm abrasion.
For more information, register free on iData's website at: http://www.idataresearch.net/idata/registration.php
About iData Research
iData Research (www.idataresearch.net/idata/discoveridata.php) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: cosmetic surgery, facial aesthetics, medical lasers, orthopedics, cardiovascular, dental, endoscopy and more.
SOURCE iData Research Inc.
Showing posts with label aesthetic. Show all posts
Showing posts with label aesthetic. Show all posts
Wednesday, November 3, 2010
Friday, July 31, 2009
New Survey Reveals High Expectations for Aesthetic Injections
SCOTTSDALE, Ariz., July 7 /PRNewswire/ -- Americans aren't willing to give up aesthetic injections and interest is growing, whether as a means to stay competitive in today's job market or simply to maintain a youthful image, the demand and want is strong. At the time of a recent Kelton Research* survey more than 40 percent of respondents were interested in receiving aesthetic botulinum toxin injections within the next six months.(1)
Despite clear interest, many expressed reluctance to having a botulinum toxin injection. In fact, one-third of those who had not yet received the treatment were worried that it would prevent them from being able to make natural facial expressions.(1)
Sixty-three percent of survey respondents who would ever consider receiving botulinum toxin injections cited that a guarantee of natural-looking results would influence their decision, demonstrating a desire for retaining a natural-looking face, and more natural-looking expressions following injection.(1)
Other top factors included more affordable costs, longer-lasting and faster-acting results.(2)
The poll found that of the respondents who had never undergone botulinum toxin injections, 36% said that their concern about no longer having a natural look had prevented them from receiving the treatment in the past.(1) Almost 60 percent of those surveyed who had not ever received an injection stated that they'd be likely to if the cost of treatment was more affordable.(1) And, of the respondents who had botulinum toxin injections, three in ten reported not seeing noticeable results for at least a week(1) and thirty percent of polled respondents said that having immediate results, such as within 24-48 hours, would positively influence their decision to undergo treatment.(2)
According to Florida dermatologist Dr. Susan Weinkle, patients want value and rapid results at a fair price. "My patients are looking for a treatment that will not make them look obvious or overdone and they want these natural looking results fast."
They are in luck: after extensive testing and clinical results, a new Botulinum Toxin A is now on the market. Dysport(TM) has been approved by the FDA for use in the United States for the temporary improvement in the appearance of moderate to severe glabellar lines - the vertical lines between the eyebrows - in adult men and women 65 or younger.
The benefits of Dysport(TM) include:
• Duration - results lasting up to four months
• Demonstrated efficacy with four repeat treatments (proving results following each treatment)
• Demonstrated safety with 12 repeat treatments
• No evidence of neutralizing antibodies
• Clinical trials included both subjects who have and have not previously been treated with a Botulinum Toxin. There was no difference in results among the two groups
•Large patient population - 4,800 treatments in 2,900 patients (with an ethnically diverse population)
*About the 2009 Botulinum Toxin survey:
Sample: 600 U.S. adults ages 25-60 with a household income of $50,000 or more, including 570 females and 300 botulinum toxin users and 300 aware of at least one nonsurgical aesthetic procedure or treatment.(2)
References:
1. Kelton Research. Botulinum Toxin Survey NewsWorthy Analysis. February--March 2009. Data on file, Medicis Pharmaceutical Corporation.
2. Kelton Research. Botulinum Toxin Survey Topline Report. February--March 2009. Data on file, Medicis Pharmaceutical Corporation.
Important Safety Information
Dysport(TM) is an acetylcholine release inhibitor and a neuromuscular blocking agent indicated for the temporary improvement in appearance of moderate to severe glabellar lines associated with procerus and corrugator muscle activity in adult patients.
Botulinum toxin effects may spread beyond the site of local injection to produce systemic symptoms of botulism such as swallowing and breathing difficulties that can occur within hours to weeks of injection. The risk of symptoms is probably greatest in children treated for spasticity, but symptoms can also occur in adults, particularly in those patents who have underlying conditions that would predispose them to these symptoms. In clinical trials, the most frequently reported adverse effects (>2%) are headache, nasopharyngitis and upper respiratory tract infection.
Dysport(TM) is not recommended for children or pregnant women. Re-treatment with Dysport(TM) should be administered no more than every three months.
SOURCE Medicis Aesthetics Inc
Despite clear interest, many expressed reluctance to having a botulinum toxin injection. In fact, one-third of those who had not yet received the treatment were worried that it would prevent them from being able to make natural facial expressions.(1)
Sixty-three percent of survey respondents who would ever consider receiving botulinum toxin injections cited that a guarantee of natural-looking results would influence their decision, demonstrating a desire for retaining a natural-looking face, and more natural-looking expressions following injection.(1)
Other top factors included more affordable costs, longer-lasting and faster-acting results.(2)
The poll found that of the respondents who had never undergone botulinum toxin injections, 36% said that their concern about no longer having a natural look had prevented them from receiving the treatment in the past.(1) Almost 60 percent of those surveyed who had not ever received an injection stated that they'd be likely to if the cost of treatment was more affordable.(1) And, of the respondents who had botulinum toxin injections, three in ten reported not seeing noticeable results for at least a week(1) and thirty percent of polled respondents said that having immediate results, such as within 24-48 hours, would positively influence their decision to undergo treatment.(2)
According to Florida dermatologist Dr. Susan Weinkle, patients want value and rapid results at a fair price. "My patients are looking for a treatment that will not make them look obvious or overdone and they want these natural looking results fast."
They are in luck: after extensive testing and clinical results, a new Botulinum Toxin A is now on the market. Dysport(TM) has been approved by the FDA for use in the United States for the temporary improvement in the appearance of moderate to severe glabellar lines - the vertical lines between the eyebrows - in adult men and women 65 or younger.
The benefits of Dysport(TM) include:
• Duration - results lasting up to four months
• Demonstrated efficacy with four repeat treatments (proving results following each treatment)
• Demonstrated safety with 12 repeat treatments
• No evidence of neutralizing antibodies
• Clinical trials included both subjects who have and have not previously been treated with a Botulinum Toxin. There was no difference in results among the two groups
•Large patient population - 4,800 treatments in 2,900 patients (with an ethnically diverse population)
*About the 2009 Botulinum Toxin survey:
Sample: 600 U.S. adults ages 25-60 with a household income of $50,000 or more, including 570 females and 300 botulinum toxin users and 300 aware of at least one nonsurgical aesthetic procedure or treatment.(2)
References:
1. Kelton Research. Botulinum Toxin Survey NewsWorthy Analysis. February--March 2009. Data on file, Medicis Pharmaceutical Corporation.
2. Kelton Research. Botulinum Toxin Survey Topline Report. February--March 2009. Data on file, Medicis Pharmaceutical Corporation.
Important Safety Information
Dysport(TM) is an acetylcholine release inhibitor and a neuromuscular blocking agent indicated for the temporary improvement in appearance of moderate to severe glabellar lines associated with procerus and corrugator muscle activity in adult patients.
Botulinum toxin effects may spread beyond the site of local injection to produce systemic symptoms of botulism such as swallowing and breathing difficulties that can occur within hours to weeks of injection. The risk of symptoms is probably greatest in children treated for spasticity, but symptoms can also occur in adults, particularly in those patents who have underlying conditions that would predispose them to these symptoms. In clinical trials, the most frequently reported adverse effects (>2%) are headache, nasopharyngitis and upper respiratory tract infection.
Dysport(TM) is not recommended for children or pregnant women. Re-treatment with Dysport(TM) should be administered no more than every three months.
SOURCE Medicis Aesthetics Inc
Wednesday, April 29, 2009
Herbal Supplements Put Aesthetic Surgery Patients At Risk
For many people, the words "natural" or "herbal" are virtually synonymous with safety and purity. Products available over-the-counter without a doctor's prescription are often mistakenly believed to be free of significant risks. A report in the March/April issue of Aesthetic Surgery Journal warns that more than 40% of plastic surgery patients use herbal supplements in the two weeks prior to undergoing surgery. And, while some herbal supplements may provide benefits during recovery, commonly used herbal medications such as ginkgo biloba, ginseng, garlic, echinacea, valerian root and others can have deleterious effects when combined with surgery.
When undergoing plastic surgery, the most significant and potentially dangerous effects of alternative medicines occur during the operative and immediate postoperative periods. "In considering the dizzying array of supplements available, the main concerns of the plastic surgeon are interaction with other medications, cardiovascular effects, alteration of coagulation [bleeding] and sedative effects," says David J. Rowe, MD, lead author and Assistant Professor of Plastic Surgery at University Hospitals Case Medical Center, Lyndhurst, OH.
For more information about Laser Skin treatments at Derma Health Institute, go to:http://www.dermahealthinstitute.com
Unfortunately, as many as 70% of patients may not disclose the use of alternative medications to their surgeon or conventional health care provider, sometimes because they feel these physicians have little knowledge or interest in naturopathic medicine, or they feel physicians may disapprove of such treatments. Some patients simply fail to recognize the relevance of supplement usage to their current medical or surgical care. Patients need to be aware that full disclosure of all medications - both those that are prescribed and those that are obtained over-the-counter - is extremely important to their health and safety. They should also understand that inconsistent and unregulated manufacturing standards and lack of regulation for many herbal supplements mean that quality and dosage may vary considerably among products.
"This article was written to help plastic surgeons and their patients identify potentially harmful herbal supplements, based on the most current scientific research," says Dr. Rowe. "On the positive side, we also discuss how providing the correct supplements and nutrients after aesthetic surgery can be very therapeutic."
The authors recommend that patients be provided with a comprehensive list of supplements that must be avoided in the perioperative period to minimize potential surgical complications.
"Despite the fact that the dangerous side effects of some herbal supplements have been widely publicized, plastic surgeons still find that many patients do not fully appreciate the importance of discontinuing these treatments before surgery," says Alan Gold, MD, president of the American Society for Aesthetic Plastic Surgery (ASAPS). "Physicians must have at least fundamental knowledge of the common herbal medications and their effects, and then be very proactive in discussing patients' use of herbal supplements during the history, consultation and informed consent process. Stopping certain herbal supplements prior to surgery is just as critical as stopping aspirin, ibuprofen and many other common drugs."
About ASJ
Aesthetic Surgery Journal, owned by the American Society for Aesthetic Plastic Surgery and published by Elsevier Science, is a peer-reviewed international journal focusing on clinical and scientific developments in cosmetic surgery and cosmetic medicine. The Journal has subscribers in more than 80 countries. Besides its affiliation with ASAPS, the leading organization of board-certified plastic surgeons who specialize in aesthetic surgery, ASJ is also the official English-language journal of plastic surgery societies in Brazil, Israel, Mexico, Japan, Korea, Thailand, Costa Rica, Colombia, India and The Netherlands, and it is the official journal of the Rhinoplasty Society. ASJ's Editorial Board includes plastic surgeons and Interspecialty Editors representing anesthesiology, dermatology, ophthalmology, otolaryngology and clinical psychology. For information on the Journal, as well as subscriber and pay-per-view access to the Journal's full text and graphics, go to www.aestheticsurgeryjournal.com About ASAPS
The American Society for Aesthetic Plastic Surgery, the leading organization of board-certified plastic surgeons specializing in cosmetic plastic surgery includes Active-Member plastic surgeons certified by the American Board of Plastic Surgery or the Royal College of Physicians and Surgeons of Canada, as well as International Active Members who hold equivalent credentials in their own countries. For information, visit www.surgery.org
For more information about Laser Skin treatments at Derma Health Institute, go to:http://www.dermahealthinstitute.com
About ASAPS
The 2400-member American Society for Aesthetic Plastic Surgery (ASAPS), founded in 1967, is the leading organization of ABMS-certified plastic surgeons who specialize in cosmetic plastic surgery. With ASAPS active members certified by the American Board of Plastic Surgery, Canadian active members certified by the Royal College of Physicians and Surgeons of Canada, and International members certified in their countries of origin, ASAPS is at the forefront of innovation in aesthetic plastic surgery. Toll-free referral line: 888.ASAPS.11 (272.7711). Web site:www.surgery.org
When undergoing plastic surgery, the most significant and potentially dangerous effects of alternative medicines occur during the operative and immediate postoperative periods. "In considering the dizzying array of supplements available, the main concerns of the plastic surgeon are interaction with other medications, cardiovascular effects, alteration of coagulation [bleeding] and sedative effects," says David J. Rowe, MD, lead author and Assistant Professor of Plastic Surgery at University Hospitals Case Medical Center, Lyndhurst, OH.
For more information about Laser Skin treatments at Derma Health Institute, go to:http://www.dermahealthinstitute.com
Unfortunately, as many as 70% of patients may not disclose the use of alternative medications to their surgeon or conventional health care provider, sometimes because they feel these physicians have little knowledge or interest in naturopathic medicine, or they feel physicians may disapprove of such treatments. Some patients simply fail to recognize the relevance of supplement usage to their current medical or surgical care. Patients need to be aware that full disclosure of all medications - both those that are prescribed and those that are obtained over-the-counter - is extremely important to their health and safety. They should also understand that inconsistent and unregulated manufacturing standards and lack of regulation for many herbal supplements mean that quality and dosage may vary considerably among products.
"This article was written to help plastic surgeons and their patients identify potentially harmful herbal supplements, based on the most current scientific research," says Dr. Rowe. "On the positive side, we also discuss how providing the correct supplements and nutrients after aesthetic surgery can be very therapeutic."
The authors recommend that patients be provided with a comprehensive list of supplements that must be avoided in the perioperative period to minimize potential surgical complications.
"Despite the fact that the dangerous side effects of some herbal supplements have been widely publicized, plastic surgeons still find that many patients do not fully appreciate the importance of discontinuing these treatments before surgery," says Alan Gold, MD, president of the American Society for Aesthetic Plastic Surgery (ASAPS). "Physicians must have at least fundamental knowledge of the common herbal medications and their effects, and then be very proactive in discussing patients' use of herbal supplements during the history, consultation and informed consent process. Stopping certain herbal supplements prior to surgery is just as critical as stopping aspirin, ibuprofen and many other common drugs."
About ASJ
Aesthetic Surgery Journal, owned by the American Society for Aesthetic Plastic Surgery and published by Elsevier Science, is a peer-reviewed international journal focusing on clinical and scientific developments in cosmetic surgery and cosmetic medicine. The Journal has subscribers in more than 80 countries. Besides its affiliation with ASAPS, the leading organization of board-certified plastic surgeons who specialize in aesthetic surgery, ASJ is also the official English-language journal of plastic surgery societies in Brazil, Israel, Mexico, Japan, Korea, Thailand, Costa Rica, Colombia, India and The Netherlands, and it is the official journal of the Rhinoplasty Society. ASJ's Editorial Board includes plastic surgeons and Interspecialty Editors representing anesthesiology, dermatology, ophthalmology, otolaryngology and clinical psychology. For information on the Journal, as well as subscriber and pay-per-view access to the Journal's full text and graphics, go to www.aestheticsurgeryjournal.com About ASAPS
The American Society for Aesthetic Plastic Surgery, the leading organization of board-certified plastic surgeons specializing in cosmetic plastic surgery includes Active-Member plastic surgeons certified by the American Board of Plastic Surgery or the Royal College of Physicians and Surgeons of Canada, as well as International Active Members who hold equivalent credentials in their own countries. For information, visit www.surgery.org
For more information about Laser Skin treatments at Derma Health Institute, go to:http://www.dermahealthinstitute.com
About ASAPS
The 2400-member American Society for Aesthetic Plastic Surgery (ASAPS), founded in 1967, is the leading organization of ABMS-certified plastic surgeons who specialize in cosmetic plastic surgery. With ASAPS active members certified by the American Board of Plastic Surgery, Canadian active members certified by the Royal College of Physicians and Surgeons of Canada, and International members certified in their countries of origin, ASAPS is at the forefront of innovation in aesthetic plastic surgery. Toll-free referral line: 888.ASAPS.11 (272.7711). Web site:www.surgery.org
Subscribe to:
Posts (Atom)